Beneficial effect of blood transfusion in children with sickle cell chest syndrome
- PMID: 3341320
- DOI: 10.1001/archpedi.1988.02150020080034
Beneficial effect of blood transfusion in children with sickle cell chest syndrome
Abstract
Reports in the 1970s suggested that acute chest syndrome (ACS) in children with sickle cell disease is usually due to bacterial infection. Studies in adults and more recently in children, however, showed that proved bacterial infection occurs in a minority of these patients and that vascular occlusion is the main pathologic process. In a retrospective study of 32 episodes of ACS in children, a definite bacterial infection was found in 3% (one patient), possible bacterial infection in 11% (four patients), and a possible mycoplasma in 13% (five patients). With the intent to dilute sickle cells, 23 patients received blood transfusion within 24 hours after hospital admission; all showed a dramatic clinical and roentgenographic improvement. Of the nine patients who did not receive a transfusion after hospital admission, the conditions of five patients deteriorated but improved after "late" transfusion; three patients showed slow improvement, and only one patient improved within 48 hours. From this we conclude that vascular occlusion might be the main process in ACS and that early blood transfusion may be valuable in shortening the course and decreasing mortality. The low hemoglobin value at presentation in our patients makes dilution of sickle cells possible by packed red blood cell transfusion rather than exchange transfusion.
Similar articles
-
Mycoplasma disease and acute chest syndrome in sickle cell disease.Pediatrics. 2003 Jul;112(1 Pt 1):87-95. doi: 10.1542/peds.112.1.87. Pediatrics. 2003. PMID: 12837872
-
Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.Am J Hematol. 2004 May;76(1):19-25. doi: 10.1002/ajh.20054. Am J Hematol. 2004. PMID: 15114592 Clinical Trial.
-
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.N Engl J Med. 2000 Jun 22;342(25):1855-65. doi: 10.1056/NEJM200006223422502. N Engl J Med. 2000. PMID: 10861320
-
Acute chest syndrome and sickle cell disease.Curr Opin Hematol. 1998 Mar;5(2):89-92. doi: 10.1097/00062752-199803000-00002. Curr Opin Hematol. 1998. PMID: 9570700 Review.
-
[The sickle cell anemia lung from childhood to adulthood].Rev Mal Respir. 1998 Apr;15(2):159-68. Rev Mal Respir. 1998. PMID: 9608986 Review. French.
Cited by
-
The role of preventive medicine in sickle cell disease. The Watson Smith lecture.J R Coll Physicians Lond. 1996 Jan-Feb;30(1):37-41. J R Coll Physicians Lond. 1996. PMID: 8745362 Free PMC article. Review.
-
Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE).Br J Haematol. 2012 Jun;157(5):627-36. doi: 10.1111/j.1365-2141.2012.09105.x. Epub 2012 Mar 30. Br J Haematol. 2012. PMID: 22463614 Free PMC article. Clinical Trial.
-
Triaging acute chest syndrome clinical decision-making using bedside SaO2/FiO2 ratio.Blood Adv. 2025 Jun 24;9(12):2970-2979. doi: 10.1182/bloodadvances.2024015139. Blood Adv. 2025. PMID: 40179390 Free PMC article.
-
Identification of Clinical and Laboratory Parameters Associated with the Development of Acute Chest Syndrome during Vaso-Occlusive Episodes in Children with Sickle Cell Disease: A Preliminary Step before Assessing Specific and Early Treatment Strategies.J Clin Med. 2019 Nov 1;8(11):1839. doi: 10.3390/jcm8111839. J Clin Med. 2019. PMID: 31683997 Free PMC article.
-
Indications for transfusion in the management of sickle cell disease.Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):696-703. doi: 10.1182/hematology.2021000307. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889416 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical